Skip to main content
# Title Department Research Year
81 New pyrimidine/thiazole hybrids endowed with analgesic, anti-inflammatory, and lower cardiotoxic activities: Design, synthesis, and COX-2/sEH dual inhibition Department of Pharmaceutical Organic Chemistry 2022
82 Diverse Glycosides from Gardenia latifolia with Antiviral Activity and Chemosystematic Signifcance Department of Pharmacognosy 2022
83 Chitosan Nanoparticles for Meloxicam Ocular Delivery: Development, In Vitro Characterization, and In Vivo Evaluation in a Rabbit Eye Model Department of Pharmaceutics 2022
84 Diterpenoids profile of the marine sponge Chelonaplysilla erecta and candidacy as potential antitumor drugs investigated by molecular docking and pharmacokinetic studies Department of Pharmaceutical Organic Chemistry 2022
85 New 1, 3, 4‐oxadiazoles linked with the 1, 2, 3‐triazole moiety as antiproliferative agents targeting the EGFR tyrosine kinase Department of Pharmaceutical Organic Chemistry 2022
86 mRNA-loaded lipid nanoparticles targeting immune cells in the spleen for use as cancer vaccines Department of Pharmaceutics 2022
87 Double-signal quantification of amoxicillin based on interaction with 4-aminoantipyrine at copper and nitrogen co-doped carbon quantum dots as an artificial nanozyme Department of Pharmaceutical Analytical Chemistry 2022
88 Phytochemical investigation, molecular docking studies and DFT calculations on the antidiabetic and cytotoxic activities of Gmelina philippensis CHAM. Department of Medicinal Chemistry 2022
89 Tailoring of novel azithromycin loaded zinc oxide nanoparticles for wound healing Department of Microbiology and Immunology 2022
90 New 1,3,4-Oxadiazole-Chalcone/Benzimidazole Hybrids as Potent Anti-proliferative Agents Department of Pharmaceutical Organic Chemistry 2022